Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV002287505 | SCV002577825 | uncertain significance | See cases | 2021-12-10 | criteria provided, single submitter | clinical testing | ACMG categories: PM1,PM2,BP1 |
Fulgent Genetics, |
RCV002477894 | SCV002778775 | uncertain significance | Hypertrophic cardiomyopathy 1; Myopathy, myosin storage, autosomal recessive; Myosin storage myopathy; Congenital myopathy with fiber type disproportion; Dilated cardiomyopathy 1S; MYH7-related skeletal myopathy | 2021-10-26 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004008967 | SCV004824853 | uncertain significance | Cardiomyopathy | 2023-10-27 | criteria provided, single submitter | clinical testing | This missense variant replaces asparagine with aspartic acid at codon 1824 of the MYH7 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with hypertrophic cardiomyopathy (PMID: 33495596). This variant has been identified in 3/282702 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Clinical Genetics, |
RCV001700538 | SCV001922471 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001700538 | SCV001963444 | uncertain significance | not provided | no assertion criteria provided | clinical testing |